SecBot SecBot
8-K ·Filed Aug 17, 2026

VANI

Vivani Medical, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago SEC0001753926-26-001536
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This filing is routine and non-material. Monitor upcoming quarterly results (10-Q) or clinical trial updates for the next catalyst. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
VANI ▼ -8.89% at T+20d
NEUTRAL call -8.89% · α vs SPY -6.91% · entry $1.35 → $1.23
Next anchor: T+60d in 14d
Latest observation: T+48 -19.83% FF3 residual α
Entry = T+0 close
Aug 17, 2026
via day close
T+1d
+7.41%
call +7.41% · α +8.08%
$1.45
settled 2mo ago
T+5d
+2.22%
call +2.22% · α +3.41%
$1.38
settled 2mo ago
T+20d
-8.89%
call -8.89% · α -6.91%
$1.23
settled 6w ago
T+60d
Pending
in 14d

Price Chart

Loading chart...

Executive Summary

Vivani Medical filed an 8-K under Item 7.01 to furnish a routine investor slide presentation dated August 17, 2026. The filing contains no material financial data, guidance updates, or preliminary results—it is a standard periodic disclosure of business summary slides used at industry conferences.

Key Facts

  • Filed Form 8-K on August 17, 2026, with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits).
  • Attached slide presentation (Exhibit 99.1) provides general business updates and summaries for investor conferences.
  • No forward guidance, preliminary financial results, or quantitative metrics were disclosed in the filing text.
  • Slide content was not textually extracted—only the filing metadata and exhibit list are available.
  • Company expressly disclaims any obligation to update the presentation.

Financial Impact

No financial figures disclosed. Filing is a routine business update with no quantified impact.

Risk Factors

  • No material information disclosed—stock movement may be driven by slide content (not extracted here).
  • Absence of guidance or performance data leaves visibility unchanged.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001753926-26-001536
Document: 0001753926-26-001536-index-headers.html0001753926-26-001536
Document: 0001753926-26-001536-index.html0001753926-26-001536
Document: 0001753926-26-001536.txt0001753926-26-001536
8 reports for VANI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VANI — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
424B5
BEARISH ★ 5/10
$1.25 $1.13▲ +9.60%▲ +9.57%$1.17 (+6.48%)
Aug 17, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$1.35 $1.23▼ −8.89%▼ −6.91%$1.17 (−13.41%)
Jul 16, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$1.35 $1.34▼ −0.74%▼ −4.36%$1.17 (−13.41%)
Jul 7, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$1.35 $1.33▼ −1.48%▼ −2.81%$1.17 (−13.41%)
Jul 2, 2026
16w ago
Press Release
NEUTRAL ★ 5/10
$1.26 $1.30▲ +3.17%▲ +3.59%$1.17 (−7.22%)
Jun 30, 2026
17w ago
8-K
BULLISH ★ 5/10
$1.24 $1.30▲ +4.84%▲ +5.87%$1.17 (−5.73%)
Jun 4, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$1.28 $1.26▼ −1.56%▼ −0.19%$1.17 (−8.67%)
Mar 26, 2026
30w ago
Press Release
MIXED ★ 6/10
$1.02 $1.39▲ +36.27%▲ +23.53%$1.17 (+14.61%)
Showing 8 of 8

US Market Status

Market Open — Closes in 5h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026